MarketFriction

Gayatri BioOrganics Ltd

BSE 524564 · Commodity Chemicals
₹7.90 +1.41%
BSE close2026-10-01
Market cap₹62.3 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.000.000.000.000.000.000.000.000.000.000.002.34
Expenses0.070.100.180.150.110.080.100.180.120.130.322.33
Operating Profit-0.07-0.10-0.18-0.15-0.11-0.08-0.10-0.18-0.12-0.13-0.320.01
OPM %0.43%
Other Income0.000.000.000.000.000.000.000.000.000.000.000.00
Interest0.040.040.050.060.070.080.070.080.090.090.100.11
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.11-0.14-0.23-0.21-0.18-0.16-0.17-0.26-0.21-0.22-0.42-0.10
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-0.11-0.14-0.23-0.21-0.18-0.16-0.17-0.26-0.21-0.22-0.42-0.10
EPS in Rs-0.01-0.02-0.03-0.03-0.02-0.02-0.02-0.03-0.03-0.03-0.05-0.01
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales137.2279.32173.32155.480.000.000.001.670.000.000.002.34
Expenses162.03128.53197.18159.090.610.500.502.440.530.450.752.90
Operating Profit-24.81-49.21-23.86-3.61-0.61-0.50-0.50-0.77-0.53-0.45-0.75-0.56
OPM %-18.08%-62.04%-13.77%-2.32%-46.11%-23.93%
Other Income0.96-16.5311.872.1085.090.000.000.000.000.000.000.00
Interest12.7411.570.194.710.010.000.000.030.150.280.360.39
Depreciation2.135.346.969.290.000.000.000.000.000.000.000.00
Profit before tax-38.72-82.65-19.14-15.5184.47-0.50-0.50-0.80-0.68-0.73-1.11-0.95
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%26.25%0.00%0.00%0.00%
Net Profit-38.73-82.65-19.14-15.5184.47-0.50-0.50-1.01-0.68-0.73-1.11-0.95
EPS in Rs-6.27-10.49-2.43-1.9710.72-0.06-0.06-0.13-0.09-0.09-0.14-0.12
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%%%%
Compounded Profit Growth7%%-3%-23%
Stock Price CAGR-6%-5%-11%-36%
Return on Equity%%%%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital50.9261.7878.7978.7978.7978.7978.7978.7978.7978.7978.7978.79
Reserves-40.86-79.58-159.93-181.20-195.74-111.27-111.77-112.26-113.27-113.95-114.68-115.79
Borrowings88.12115.5035.1135.1135.1135.1135.1135.1135.6636.3636.9036.98
Other Liabilities43.9444.00150.81212.77226.930.460.470.600.440.370.661.74
Total Liabilities142.12141.70104.78145.47145.093.092.602.241.621.571.671.72
Fixed Assets47.1945.690.000.000.000.000.000.000.000.000.000.00
CWIP5.806.010.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets89.1390.00104.78145.47145.093.092.602.241.621.571.671.72
Total Assets142.12141.70104.78145.47145.093.092.602.241.621.571.671.72
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity1.07-26.48-13.76-2.62-0.5984.59-0.52-0.40-0.56-0.69-0.55-0.08
Cash from Investing Activity-7.10-1.42-0.752.620.82-83.860.000.000.000.000.000.00
Cash from Financing Activity4.4828.0215.530.000.00-0.010.000.000.560.700.540.74
Net Cash Flow-1.550.121.020.000.230.73-0.52-0.40-0.010.01-0.010.66
Free Cash Flow-5.04-28.17-16.06-2.62-0.5984.59-0.52-0.40-0.56-0.69-0.55-0.08
CFO/OP7%107%28%11%16%-13,867%104%80%73%130%122%11%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days63.12116.056.953.181.2254.64
Inventory Days62.8798.300.000.000.000.00
Days Payable58.8079.17
Cash Conversion Cycle67.19135.186.953.181.2254.64
Working Capital Days5.32-103.13-365.55-212.09-271.31-7,048.65
ROCE %14.68%-27.28%-209.87%-21.01%-26.53%-54.61%-44.54%-40.72%-151.52%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters40.63%40.63%40.63%40.63%40.62%43.78%21.59%21.59%21.59%21.59%21.59%21.59%
FIIs0.00%0.00%0.00%0.00%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
DIIs0.66%0.66%0.66%0.66%0.65%0.65%0.65%0.65%0.65%0.65%0.65%0.23%
Public58.71%58.70%58.71%58.70%58.71%55.56%77.76%77.75%77.77%77.76%77.75%78.17%
No. of Shareholders27,56928,09631,82532,87433,80133,73433,44132,74932,12331,47130,79630,442

Fundamentals

Market Cap₹ 62.3 Cr.
Current Price₹ 7.91
Book Value₹ -4.70
ROCE-152 %
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)-23%
Standalone figures.
Valuation
Market capRs 62 Cr
Enterprise valueRs 99 Cr
Price to book-1.68x
Earnings yield-1.53%
P/B, 3-year average-1.85x
P/B, 5-year average-2.32x
Profitability
Net margin, latest quarter-4.27%
ROE3.05%
ROCE-151.52%
ROA-65.49%
ROE, 3-year average2.35%
ROCE, 3-year average-78.93%
ROA, 3-year average-51.06%
ROE, 5-year average2.31%
ROCE, 5-year average-63.58%
ROA, 5-year average-45.23%
Per share
EPS (TTM)Rs -0.12
EPS (latest year)Rs -0.14
EPS (latest quarter)Rs -0.01
EPS, 3-year averageRs -0.11
EPS, 5-year averageRs -0.10
Book value per shareRs -4.70
Cash flow per shareRs -0.01
Free cash flow per shareRs -0.01
Efficiency
Creditor days79 days
Cash conversion cycle55 days
Working capital days-7049 days
Leverage
Total debtRs 37 Cr
Cash and bankRs 0 Cr
Net debtRs 37 Cr
Debt to equity-1.00x
Interest coverage-1.44x
Owners' fund to total sources-2151.16%
Debt to assets2150.00%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Financing Activity (latest year)Rs 1 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -0 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Statement figures
Sales (latest quarter)Rs 2 Cr
Operating profit (latest quarter)Rs 0 Cr
EBITDA (TTM)Rs -1 Cr
PBDT (TTM)Rs -1 Cr
Profit before tax (TTM)Rs -1 Cr
Net profit (TTM)Rs -1 Cr
Net profit (latest year)Rs -1 Cr
Net profit (latest quarter)Rs -0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 79 Cr
ReservesRs -116 Cr
Shareholders' fundsRs -37 Cr
Total assetsRs 2 Cr
ReceivablesRs 0 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)7.88
Ownership
Promoter holding21.59% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Period524564Nifty 50Difference
1 week+0.6%-2.8% +3.4 pts
1 month+4.9%-6.8% +11.7 pts
3 months+5.6%-7.6% +13.2 pts
3 years-26.6%+14.2% -40.8 pts
5 years-17.1%+27.9% -45.0 pts

Red flags

F-score 3 of 6
seriousNegative equity Shareholders' equity is negative
lookRepeated losses Net loss in each of the last two years
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹2 Cr. Net loss ₹0 Cr.

Activity

Compare
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Gayatri BioOrganics Ltd?

Gayatri BioOrganics Ltd (524564) has a market capitalisation of Rs 62.3 Cr. at the 2026-10-01 close.

What were Gayatri BioOrganics Ltd's latest quarterly results?

In the Jun 2026 quarter, Gayatri BioOrganics Ltd sales was Rs 2 Cr with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03